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Background: Cartilage is an avascular and aneural tissue. Chondrocytes thrive in this restricted environment of low
oxygen tension and poor nutrient availability which has led to suggestions that hypoxia may be a protective
mechanism against the development of osteoarthritis (OA). There is also a growing body of evidence to support
the role of epigenetic factors in the pathogenesis of OA. However, few studies have investigated the epigenetic-OA
process within a hypoxic environment. The current study has investigated the effects of hypoxia on gene expression
and DNA methylation of anabolic and catabolic genes involved in the pathogenesis of OA.
Methods: Chondrocytes extracted from OA femoral heads were incubated in normoxia and hypoxia (20% and 2%
oxygen concentrations respectively). Interleukin 1-beta (IL-1β) plus oncostatin M (OSM), 5-azadeoxycytidine (5-aza-dC)
or media alone (control) were added twice weekly to the incubated samples. After 5 weeks, levels of Collagen type IX
(COL9A1), IL1B, and matrix metalloproteinase-13 (MMP13) gene expression were measured using SYBR Green-based
qRT-PCR and were correlated with methylation status analysed by pyrosequencing methodology.
Results: Hypoxia resulted in a >50-fold and >10-fold increase in relative expression of COL9A1 and IL1B respectively.
This was inversely correlated to the DNA methylation status of these genes. Expression of MMP13 was reduced at 2%
oxygen tension in control cells. Relative expression of MMP13 increased in cells stimulated with IL-1β and 5-aza-dC in
normoxic conditions, and this effect was eliminated at low oxygen tension although no correlation with methylation
status was observed.
Conclusions: These findings demonstrate a role for hypoxia in the regulation of anabolic and catabolic gene
expression and the influence of changes in DNA methylation. These results further support the role of epigenetics in
OA and, critically, highlight the complex relationship between the physiological environment of cartilaginous cells and
the osteoarthritic process with implications for therapeutic intervention and our understanding of OA pathophysiology.
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Osteoarthritis (OA) is a clinical syndrome characterized
by joint pain, functional limitation and often reduced
quality of life. Epidemiological studies have shown OA
represents one of the leading causes of pain and disabil-
ity worldwide [1]. An essential feature of the underlying
pathogenesis of OA is an imbalance of anabolic and* Correspondence: roco@soton.ac.uk
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unless otherwise stated.catabolic activity leading to progressive loss and destruc-
tion of extracellular matrix (ECM) of articular cartilage
[2]. This is exemplified by the aberrant expression of a
myriad of catabolic genes, including matrix metalloprotein-
ases (MMPs), aggrecanases (ADAMTS4 and ADAMTS5),
inducible nitric oxide synthetase, prostaglandins [3],
interleukin-1β (IL1B) and a number of cytokines [4],
and genes [5,6].
The influence of genetic susceptibility on the aetiology
of OA has been demonstrated in large epidemiological
studies, that have characterised OA risk alleles from
genome wide association analysis [7]. However, there isLtd. This is an Open Access article distributed under the terms of the Creative
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genetics in the pathogenesis of OA. There are three funda-
mental epigenetic processes: DNA methylation, histone
modifications, and non-coding RNAs. DNA methylation
is thought to be the principle epigenetic process and has
been the subject of intense research [8].
DNA methylation is generally stable in somatic cells
throughout adult life [9,10]. Genes that are expressed in
terminally differentiated cells demonstrate hypomethylated
DNA corresponding with an open structure allowing the
binding of specific transcription factors. In contrast, genes
that do not play a role in a cells function are, typically, si-
lenced by hypermethylation [11]. Epigenetic disruption
may silence normally expressed genes or induce expres-
sion of previously silent genes [12]. This process is thought
to be the driver of a number of chronic disease states.
Studies have demonstrated hypomethylation at specific
CpG sites of catabolic genes in degradative OA chon-
drocytes [13-15] and, critically, alterations in DNA
methylation status in OA may be driven by inflammatory
cytokines [11].
Articular cartilage is comprised predominantly of
avascular, aneural and alymphatic extracellular matrix,
synthesized by sparsely distributed chondrocytes, adapted
to oxygen and nutrient limited environments [16]. Low
oxygen tensions (<5%) have been shown to promote cell
survival when cultured in vitro as well as to promote ana-
bolic cell activity and cartilage ECM synthesis compared
with culture under normoxic conditions [17,18]. More
recently, modulation of oxygen tensions comparable to
that of physiological conditions within human articular
cartilage has been shown to reduce the activity of cata-
bolic enzymes implicated in cartilage breakdown such
as MMP-1 and MMP-13 [19].
Investigations into the effects of oxygen tension of ar-
ticular cartilage have to date focused on gene expression
of anabolic and catabolic markers, with no reported lit-
erature on modulation of the epigenetic processes. The
current study has examined the effects of hypoxia on
gene expression and DNA methylation, of anabolic and
catabolic genes, involved in the pathogenesis of OA.
Methods
Cartilage dissection and chondrocyte isolation
Human OA articular cartilage was obtained from 5 patients
following total hip arthroplasty (3 men and 2 women with
a mean ± SD age of 75.2 ± 7.3 years and an OARSI modified
Mankin score of 3–5) [20]. Informed consent was obtained
from all patients, and the study was approved by the
Southampton & South West Hampshire Local Research
Ethics Committee. Only chondrocytes from the superficial
layer of OA cartilage were isolated as previously described
[21]. Briefly, the cartilage was cut into small fragments
and digested by sequential treatment with 10% trypsin(Lonza) in PBS for 30 minutes; 1 mg/ml of hyaluronidase
(Sigma-Aldrich) in PBS for 15 minutes and finally col-
lagenase B (Roche Applied Science) in DMEM/F12
(Life Technologies) for 12–15 hours at 37°C.
Culture and treatment of OA chondrocytes in hypoxia
versus normoxia
Isolated OA chondrocytes from each donor were divided
into three groups and cultured in monolayer: i) control
culture, ii) 2 μM 5-azadeoxycytidine (5-aza-dC), and iii)
10 ng/ml of IL-1β plus OSM. Before treatment, chondro-
cytes were cultured for several days at a density of 2–4 ×
105 cells in DMEM/F12 supplemented with 5% of fetal
calf serum (FCS; Invitrogen, Paisley, UK), 1% insulin–
transferrin–selenium (Sigma-Aldrich), 100 units/ml of
penicillin and 100 μg/ml of streptomycin (Lonza), and
100 μg/ml of ascorbic acid (Sigma-Aldrich) in an atmos-
phere of 5% CO2 at a temperature of 37°C. After the ini-
tial incubation period and 24 hours in media without
FCS to synchronize the cells, each sample was stimu-
lated as per their conditions with DMEM/F12 supple-
mented with 5% FCS. For the 5-aza-dC group, the
histone deacetylase inhibitor trichostatin A (300 nM)
was added once, at initial treatment, to facilitate access
of 5-aza-dC, a cytidine analogue that inhibits the activ-
ity of DNMT-1 [22]. This results in the non-specific loss
of DNA methylation during cell division. For each condi-
tion, one sample was kept at 20% O2 tension (atmospheric
oxygen tension, normoxia) and one sample cultured at
2% O2 tension (hypoxia). The media was changed twice
weekly and maintained for 5 weeks until cells reached
confluence.
DNA and RNA extraction
Total RNA and genomic DNA were extracted simultan-
eously from digested samples using an AllPrep DNA/RNA
Mini kit (Qiagen), according to the manufacturer’s in-
structions. RNA was immediately reverse- transcribed
with avian myeloblastosis virus reverse transcriptase
and both oligo(dT)15 and random primers [23].
Quantitative reverse transcription –polymerase chain
reaction (qRT-PCR)
qRT-PCR was conducted using an ABI Prism 7500 detec-
tion system (Applied Biosystems). Exon-exon boundary
primers were designed with Primer Express 3.0 software
with the exception of IL1B, which was designed by and
purchased from PrimerDesign Ltd, Southampton, UK.
Primer sequences used were COL9A1 CCTGGTGCT
CTTGGTTTGA (F), CACGCTCCCCCTTTTCTC (R);
MMP13 TTAAGGAG- CATGGCGACTTCT (F), CCC
AGGAGGAAAAGCATGAG (R); IL1B TGGCAATG
AGGATGACTTGTTC (F), CTGTAGTGGTGGTCGG
AGATT (R) and GAPDH CCAGGTGGTCTCCTCTG
Figure 1 Relative expression of IL1B (A), MMP13 (B) and
COL9A1 (C) in articular OA chondrocytes under normoxic
versus hypoxic conditions analysed by qRT-PCR. Values are the
mean ± SD of triplicate determinations per sample (n = 5;
*p < 0.1; **p < 0.05).
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(R). The 20 μl reaction mixture was prepared in triplicate,
containing 300 ng of complementary DNA, 10 μl of Power
SYBR Green PCR Master Mix (Applied Biosystems) and
250 nM of each primer. Thermal cycler conditions in-
cluded an initial activation step at 95°C for 10 minutes,
followed by a 2-step PCR program of 95°C for 15 seconds
and 60°C for 60 seconds for 40 cycles. The 2-ΔΔct method
was used for relative quantification of gene expression,
and the data were normalized to GAPDH expression.
Analysis of DNA methylation by pyrosequencing
500 ng genomic DNA was bisulfite modified using EZ
DNA Methylation-Gold™ Kit (Zymo Research Corporation)
according to the manufacturer’s instructions. Promoter
regions of interest were amplified using Platinum® PCR
Supermix (Invitrogen) and purity confirmed by agarose
gel electrophoresis. Percentage DNA methylation was
quantified using primers designed with Pyrosequencing™
Assay Design Software Ver 2.0 (Qiagen) and PyroMark™
MD (Qiagen) according to the manufacturer’s instructions.
Primer sequences used were COL9A1_1 GTTGTTGTGA
GAATTAAATGGTATTAAG (F), ACACC- CAACAATC
ATTATTTATCA (R), CCCAACAATCATTATT- TATC
(Seq); COL9A1_2 AGGGATTGAAATTTAGGTTGAT (F),
AAATTCCAATAAAAATATACCCACTAA (R), GGATT-
GAAATTTAGGTTGAT (Seq); COL9A1_3 TGAGGGT-
TAAAAGTAAAGGGAGAG (F), TTTCCCCTA- TAAAT
CCCTCCTT (R), GGGAGAGAATTAGAGGTATT (Seq);
MMP13_1 AATTAGTATTAAGTTTTTTTTTATG- GAA
GT (F), TTCAACAAAATCTCAAAACCCATCTAA (R),
AAATTTTTTTTTTTTTACCTTCTAT (Seq1), CTCAAA
ACCCATCTAAC (Seq2); MMP13_2 ATGGGTTTT- GA
GATTTTG (F), ACCCCTAAATACATCTTAAATA (R), C
AATCACTTAAAAATAAACATACTT (Seq1), AATAA- T
ACCTAAAAACTATTATC (Seq2); IL1B_1 ATGGAAGG
G- TAAGGAGTAGTAA (F), CCCACATATACTAAATTT
AAA- CATTCTT (R), ATACTAAATTTAAACATTCTTC
TA (Seq); IL1B_2 ATGAAGATTGGTTGAAGAGAATTT
TAGA (F), ATTTCTCAACCTCCTACTTCTACTTTTAA
(R), ATTTTA- GAGTAGTTTGTTGTG (Seq).
Statistical analysis
Data is presented as the mean ± SD. Statistical analysis
was performed using SPSS software, version 17.0 (SPSS,
Chicago, IL) where Wilcoxon’s signed rank test was used
to compare between groups. P values less than 0.05 were
considered significant.
Results
IL1B expression is increased in OA chondrocytes cultured
under hypoxia and is correlated with loss of methylation
As a positive control, OA chondrocytes were cultured
for 5 weeks in normoxia and hypoxia, stimulated withthe cytokines IL-1β and OSM. As expected there was a
significant increase in the relative expression of IL1B in
these cells compared with controls at both oxygen ten-
sions. This effect was enhanced in hypoxia compared to
normoxia (50472 ± 67148 versus 32546 ± 23774) although
the difference between oxygen tensions did not reach stat-
istical significance (Figure 1A). OA chondrocytes cultured
in the absence of IL-1β also demonstrated increased ex-
pression of IL1B following culture in hypoxia compared
with normoxic conditions (9.41 ± 10.23) (Figure 1A).
The human IL1B promoter contains 7 CpG sites in
the 900-bp sequence upstream of exon 1 and 1 CpG site
within exon 1 [GenBank: AY137079]. When compared
with normoxia, OA chondrocytes cultured in hypoxia
displayed a 19.6% reduction and a 21.4% reduction in
methylation status at the −299 and −256 CpG sites respect-
ively (Figure 2A-B). This was found to correspond with the
changes in gene expression described above. Significant
changes in methylation status between oxygen tensions
Figure 2 Methylation status of IL1B proximal promoter in articular OA chondrocytes under normoxic versus hypoxic conditions
analysed by pyrosequencing (A); reduction on percentage methylation of specific CpG sites correlates with higher levels of gene
expression in OA disease (B). Primary OA chondrocytes were cultured with or without IL-1β + OSM and 5-aza-dC for 5 weeks. Values are the
mean ± SD (n = 5; *p < 0.1; **p < 0.05).
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sites −299, −256 and −20 (Figure 2A). Additionally, 5-aza-
dc did not alter the methylation status under different
oxygen tensions (Figure 2A).
MMP-13 expression is decreased in hypoxia conditions in
OA chondrocytes and this is not associated with loss of
DNA methylation
The human MMP13 promoter has 7 CpG sites in the
400-bp sequence upstream of exon 1 [GenBank: NG021404];
the transcription start site is located 22-bp upstream of
the ATG start codon [24]. Relative gene expression of
MMP13 was observed to decrease at physiological oxygen
tension compared with normoxia (0.14 ± 0.10) (Figure 1B).
This change in gene expression was paralleled by a signifi-
cant decrease in methylation at 4 CpG sites (Figure 3A).
MMP13 gene expression was increased in cells stimu-
lated by IL-1β (9.24 ± 8.49) and 5-aza-dC (2.75 ± 1.70)
in normoxia. This effect was virtually eliminated in cells
cultured in hypoxia (relative expression with IL-1β =
1.03 ± 1.29; relative expression with 5-aza-dc = 1.21 ± 1.30)
(Figure 1B). Examination of methylation status of cellsstimulated with IL-1β at different oxygen tensions, dem-
onstrated a similar pattern to that of gene expression at all
CpG sites except −225 (Figure 3A), however a significant
change in methylation status was only observed at CpG
site −323 (Figure 3B). Additionally, 5-aza-dc did not alter
the methylation status of MMP13 promoter under differ-
ent oxygen tensions (Figure 3A).
COL9A1 expression is increased in hypoxia with a
significant loss of methylation at two specific CpG sites
COL9A1 relative expression in OA chondrocytes cultured
under hypoxic conditions significantly increased in contrast
to cells cultured in normoxic conditions (55.92 ± 78.69;
Figure 1C). Cells stimulated with 5-aza-dC displayed in-
creased levels of COL9A1 expression following culture
in hypoxic conditions in comparison to culture under nor-
moxia, although these changes did not reach statistical
significance. There were no differences in relative gene ex-
pression between different oxygen tensions in cells stimu-
lated with IL-1β (Figure 1C).
The human COL9A1 promoter contains 8 CpG sites in the
1,000-bp sequence upstream of exon 1 [GenBank: AF036110]
Figure 3 Methylation status of MMP13 proximal promoter in articular OA chondrocytes under normoxic versus hypoxic conditions
analysed by pyrosequencing (A); methylation of specific CpG sites correlates with lower levels of gene expression (B). Primary OA
chondrocytes were cultured with or without IL-1β + OSM and 5-aza-dC for 5 weeks. Values are the mean ± SD (n = 5; *p < 0.1; **p < 0.05).
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lated with 5-aza-dC, a loss of methylation compared with
control in normoxia at CpG sites −632, −614, −599, −400,
and in hypoxia at CpG sites −632, −614 and −599 was
observed (Figure 4A). Comparison of cells stimulated by
5-aza-dC in hypoxia with similar cells in normoxia dem-
onstrated large reductions in methylation at CpG sites −632
(14.0%) and −614 (13.6%) however these changes failed to
reach significance (Figure 4A). In addition, there was no
correlation between gene expression and methylation sta-
tus at any CpG sites in control cells or cells stimulated
with IL-1β at different oxygen tensions (Figure 4A). Inter-
estingly, a significant loss of methylation was observed at
the CpG sites −400 and −95 (13.0 ± 2.1 versus 10.0 ± 2.3
and 8.8 ± 1.6 versus 5.4 ± 2.4 respectively) which may ac-
count for the increase in COL9A1 expression observed in
cells cultured under hypoxic conditions (Figure 4B).
Discussion
The current study has examined the effects of hypoxia on
the epigenetic processes governing OA catabolic genes in-
volved in bone modulation and remodelling (IL1B and
MMP13), and an OA anabolic gene vital in normal cartil-
age biology (COL9A1) [11,14]. The current study showed
that hypoxia resulted in a significant increase in COL9A1and IL1B expression that was inversely correlated to the
DNA methylation status of these genes. In addition, ex-
pression of MMP13 was reduced in 2% oxygen tension
in control cells whilst the relative expression of MMP13
increased in cells stimulated with IL-1β and 5-aza-dC in
normoxic conditions, an effect eliminated at low oxygen
tension. Previous studies have reported the promotion
of anabolic gene expression and the inhibition of cata-
bolic genes in both healthy [19,26] and OA [27] chon-
drocytes cultured in hypoxic conditions, leading to the
promotion of anabolic and inhibition of destructive pro-
cesses seen in OA. To date there have been few reports
on the relationship between oxygen tension and epigen-
etic processes in OA. Studer and colleagues in their re-
view, noted that that hypoxic repression of chondrocyte
hypertrophy is a combined effect of regulation through
different transcription factors as well as the histone dea-
cetylase HDAC4 [28].
Hypoxia inducible factors (HIFs) are transcription factor
proteins that have been shown to mediate anabolic and
catabolic responses in cartilage. Studies have shown two
main isoforms of HIFα promote hypoxia induced cartilage
production through direct binding to the master-regulator
gene SOX9 (HIF-2α), and exhibit anti-catabolic responses
through down regulation of MMP13 amongst other
Figure 4 Methylation status of COL9A1 proximal promoter in articular OA chondrocytes under normoxic versus hypoxic conditions
analysed by pyrosequencing (A); reduction in percentage of methylation of specific CpG sites correlates with higher levels of gene
expression (B). Primary OA chondrocytes were cultured with or without IL-1β + OSM and 5-aza-dC for 5 weeks. Values are the mean ± SD
(n = 5; *p < 0.1; **p < 0.05).
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processes have been linked with the regulation of HIF-
target gene expression in chondrocytes. We previously
demonstrated the inhibition of HIF-2α-dependent
transactivation in response to the methylation of CpG
sites in the hypoxia responsive element in the proximal
promoter region of MMP13 [29].
The anabolic effects of hypoxia on chondrocytes are
well documented. Several authors have demonstrated that
near cartilage physiological oxygen tensions (<5%) en-
hanced extracellular matrix synthesis in human articular
cartilage [19,26]. Furthermore, Markway et al. showed no
significant difference between healthy and OA cells [27].
The current studies support these earlier findings demon-
strating a significant increased expression in COL9A1 in
cells cultured under hypoxic conditions.
A correlation between high levels of COL9A1 expression
and loss of methylation in human fetal bone cells (HFBCs)
is known [30] and, interestingly, the degree of demethyla-
tion was inversely correlated with developmental age. In
the current study limited association between COL9A1 ex-
pression and DNA methylation levels was observed and
no correlation between hypoxia and normoxia. These dis-
crepancies may be associated with differences in cells usedbetween the two studies, including the multipotency of
HFBCs that is absent in OA chondrocytes.
Less is known about the effect of hypoxia on the regula-
tion of catabolic mechanisms in human articular chondro-
cytes. Strobel et al. demonstrated an anti-catabolic role of
physiological oxygen tension, by the reduction in activity
of MMP-1 and MMP-13 [19]. Thoms et al. reported a
similar down-regulation of MMP13 expression by hyp-
oxia; a response mediated directly by HIF-1α. However
HIF-1α also resulted in the up regulation of tissue inhibitor
of metalloproteinases 3 (TIMP-3), an endogenous in-
hibitor of MMP-13, representing two mechanisms for
the observed changes in gene expression at low oxygen
tension [26].
The effects of hypoxia on cytokine expression are less
clear. Grimshaw et al. reported a modest increase in
IL1B and transforming growth factor beta at low (<0.1%)
though not higher oxygen tensions [17]. These two factors
have antagonistic effects, the former leading to a reduction
in aggrecan expression and the stimulation of tissue inhib-
itors of metalloproteinases (TIMPs) mRNA expression,
and the latter a converse effect [31-36]. The current
studies support earlier evidence demonstrating a sig-
nificant reduction in MMP13 and an increase in IL1B
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normoxia, representing both pro- and anti-catabolic
effect. Furthermore, we demonstrate IL-1β induced in-
creased MMP13 expression under normoxic condi-
tions, suggestive of an overall catabolic effect. We have
previously reported evidence that inflammatory cyto-
kines can change the DNA methylation status at key
CpG sites leading to the long-term induction of IL1B
in OA chondrocytes [11,29]. Here we similarly report a
significant decrease in methylation at these key CpG
sites (−256 and −299 upstream of the coding start) in
cells stimulated by IL-1β compared with controls. Fur-
thermore, a significant decrease in methylation in cells
stimulated with IL-1β in hypoxia compared with nor-
moxia was observed, correlating with the increase in
expression of IL1B seen in cells stimulated with IL-1β
and cultured in hypoxia. These results suggest that
oxygen tension has a role in epigenetic processes influ-
encing OA cartilage. Whether this is a direct effect or
one governed by the effect of the hypoxic environment
on other cellular mediators is an area for further inves-
tigation. In our previous studies, treatment with the
agent 5-aza-dC induced loss of methylation in vitro at
specific CpG sites accompanied with increased expression
of IL1B [11], MMP13 [29] and, COL9A1 [37] in articular
chondrocytes cultured for 5 weeks. However, no signifi-
cant differences were observed in this regard upon com-
parison of normoxic versus hypoxic conditions.
The current studies indicate a large degree of inter-
donor variation, which may be partly the result of the
limited clinical sample size examined. However, similar
degrees of variation between samples have been ob-
served in other studies investigating the effect of hyp-
oxia on markers of hypertrophy and degeneration in
OA chondrocytes [27]. Further investigation of the ef-
fect of hypoxia on gene methylation status would neces-
sitate the use of normal cartilage as well as that of OA
donors. This raises further considerations as normal ar-
ticular cartilage is exposed to a finely regulated gradient
of oxygen tension varying from 10% at the surface to
around 1% at its deepest layer [38]. This gradient is
abolished in OA contributing to the progression of dis-
ease [39]. This gradient is important, for example, the
observation that mouse cartilage is relatively thin may
therefore not provide a sufficient diffusion barrier to
create hypoxia [26] is thought to account for interspe-
cies differences observed in studies on the effects of
hypoxia on metabolic processes of articular cartilage.
Conclusions
The current studies indicate hypoxia promotes anabolic
processes in OA cartilage and reveal a varied influence
on catabolic mechanisms in OA. Investigation into the
modulation of articular oxygen tension may aid developmentof tissue repair and bioengineering strategies in OA in-
cluding in vitro expansion of chondrocytes for cartilage
repair, and the targeting of specific molecular modulators
of pro-anabolic and anti-catabolic mechanisms in articular
cartilage. Critically, these results further support the role
of epigenetics as a potential target for the development
of strategies for reparation in OA and highlight the com-
plex relationship between the physiological environment
of cartilaginous cells and pathophysiology of OA.
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